0001214659-22-015128.txt : 20221220 0001214659-22-015128.hdr.sgml : 20221220 20221220163027 ACCESSION NUMBER: 0001214659-22-015128 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221216 FILED AS OF DATE: 20221220 DATE AS OF CHANGE: 20221220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AULT MILTON C III CENTRAL INDEX KEY: 0001212502 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40483 FILM NUMBER: 221475203 MAIL ADDRESS: STREET 1: 11411 SOUTHERN HIGHLANDS PARKWAY STREET 2: SUITE 240 CITY: LAS VEGAS STATE: NV ZIP: 89141 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alzamend Neuro, Inc. CENTRAL INDEX KEY: 0001677077 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811822909 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 3500 LENOX RD. NE STREET 2: SUITE 1500 CITY: ATLANTA STATE: GA ZIP: 30326 BUSINESS PHONE: 844-722-6333 MAIL ADDRESS: STREET 1: 3500 LENOX RD. NE STREET 2: SUITE 1500 CITY: ATLANTA STATE: GA ZIP: 30326 4 1 marketforms-57907.xml PRIMARY DOCUMENT X0306 4 2022-12-16 0001677077 Alzamend Neuro, Inc. ALZN 0001212502 AULT MILTON C III 11411 SOUTHERN HIGHLANDS PARKWAY SUITE 240 LAS VEGAS NV 89141 false false true false Common Stock 2022-12-16 4 P false 20000 0.8980 A 345000 I By Ault Alpha LP Common Stock 2022-12-19 4 P false 20000 0.8179 A 365000 I By Ault Alpha LP Common Stock 2022-12-19 4 P false 3000 0.8184 A 11041001 I By Ault Lending, LLC Common Stock 2500000 D Common Stock 14942984 I By Ault Life Sciences, Inc. Common Stock 10000000 I By Ault Life Sciences Fund, LLC Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP. The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.8184. The range of purchase prices on the transaction date was $0.8154 to $0.8198 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of BitNile Holdings, Inc. ("BH"). Mr. Ault, the Executive Chairman of BH, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC. /s/ Milton C. Ault, III 2022-12-20